Michael G. Kurilla

Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

Jelena Levitskaya, Michael Coram, Victor Levitsky et al. · Nature · 1995 · 827 citations

Life Sciences, Immunology, Molecular Biology +11

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

Melissa Haendel, Christopher G. Chute, Tellen D. Bennett et al. · Journal of the American Medical Informatics Association · 2020 · 588 citations · Full text

Public Health, Preventive Medicine, Public Health Practice +10

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

R J Murray, Michael G. Kurilla, Jill Brooks et al. · The Journal of Experimental Medicine · 1992 · 506 citations · Full text

Life Sciences, Immunology, Oncology +17

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Rajiv Khanna, Scott R. Burrows, Michael G. Kurilla et al. · The Journal of Experimental Medicine · 1992 · 390 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response

Neil Steven, Nicola Annels, Anita Kumar et al. · The Journal of Experimental Medicine · 1997 · 350 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17